690664-24-5

Basic information

• Product Name: (E)-methyl 3-(2-amino-5-cyanophenyl)acrylate
• Synonyms: (E)-methyl 3-(2-amino-5-cyanophenyl)acrylate
• CAS NO: 690664-24-5
• Molecular Weight: 202.213
• Mol File: 690664-24-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (E)-methyl 3-(2-amino-5-cyanophenyl)acrylate(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-methyl 3-(2-amino-5-cyanophenyl)acrylate(690664-24-5)
• EPA Substance Registry System: (E)-methyl 3-(2-amino-5-cyanophenyl)acrylate(690664-24-5)

Safety Data

• Hazardous Substances Data: 690664-24-5(Hazardous Substances Data)

Upstream product

• 50397-74-5 2-bromo-4-cyanoaniline 
• 292638-85-8 acrylic acid methyl ester 
• 107-83-5 2-Methylpentane 

Relevant articles and documents

IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

The present disclosure is directed to compounds of formula (Ie) and pharmaceutically acceptable salts thereof, wherein A, B, R1, R2, m, n, X1, X2, X3 and X4 are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Substituted Dihydroquinazolines II

The invention relates to substituted dihydroquinazolines and to a method for the production thereof, the use thereof for treating and/or preventing diseases and for producing drugs for treating and/or preventing diseases, in particular for the use of the inventive dihydroquinazolines in the form of antiviral agents, in particular against cytomegaloviruses.

SUBSTITUTED DIHYDROQUINAZOLINES II

The invention relates to substituted dihydroquinazolines and to a method for the production thereof, the use thereof for treating and/or preventing diseases and for producing drugs for treating and/or preventing diseases, in particular for the use of the inventive dihydroquinazolines in the form of antiviral agents, in particular against cytomegaloviruses.